Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Ellington Residential Declares Monthly Common Dividend
-
Premier Health Announces the Appointment of Bruno Morel as its New CTO
-
Guanajuato Silver Reports Year End 2023 Financial Results
-
Hecla Announces First Quarter Production
-
Power Integrations to Release First-Quarter Financial Results on May 7
-
ICYMI: SBA Administrator Guzman Highlights Memphis Small Business Ahead of Today’s Total Solar Eclipse
-
The Board of Invalda INVL proposed to allocate dividends for the year 2023
-
Cushman & Wakefield Appoints Luke Herbert as Global Treasurer
-
Draft resolutions prepared by the Board for the shareholders' meeting of Invalda INVL to be held on 30/04/2024
-
Ur-Energy Announces Appointment of New Board Members: John Paul Pressey and Elmer W. Dyke
-
Latham Expands Project Development & Finance Practice With Experienced Energy & Infrastructure Partner
-
Big Gold Announces Concurrent Non-Brokered Private Placements to Execute Mid-Year 2024 Maiden Drilling at Tabor in Thunder Bay, Ontario
-
CoreCivic Announces 2024 First Quarter Earnings Release and Conference Call Dates
-
Data4Cure Announces a Late-Breaking Abstract to Be Presented at the 2024 American Association for Cancer Research Annual Meeting
-
Abstrax and Seed Talent Partner for First of Its Kind Advanced Terpene Education and Exclusive Terpene Science Courses
-
FutureFuel to Release First Quarter 2024 Financial Results on May 9, 2024
-
Xtreme One Entertainment Announces TrillerTV as Streaming Partner for XFC 50
-
Cardinal Energy Ltd. Announces April Dividend
-
Quarterhill Announces Closing of Red Fox Acquisition
-
Sherritt Provides Notice of First Quarter 2024 Results Conference Call
-
Source Energy Services Announces Upcoming Earnings Release
-
New SWaP Optimized Nuclear Event Detector Provides 4X Greater Sensitivity and Added Functionality
-
Pacific Life Launches New Flagship Indexed Universal Life Insurance Product
-
E-PASS Customers Can Save on Monthly Bill as Part of State’s Toll Relief Program
-
Board-Certified and Highly Accomplished, Active Duty Military Ophthalmologist Now Treating Patients at LasikPlus Louisville
-
Major Tenant Occupies Presidio Property Trust North Dakota Property
-
Mullen Group Ltd. 2024 First Quarter Earnings Conference Call and Webcast
-
Alloy Receives Significant Investment from Purpose Group to Accelerate Growth Strategy
-
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2023
-
Health workers call on senators to consider Territorians' health ahead of Middle Arm precinct hearings
-
Richmond American Announces Grand Opening in Monument
-
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against AXT, Inc. (AXTI)
-
Exco Technologies Limited Announces Second Quarter Results on May 1, 2024
-
Melbourne public transport services sit idle while apartment numbers boom
-
Dundee Precious Metals Delivers Strong First Quarter Gold Production; Announces Timing of First Quarter Financial Results
-
Peapack Private Announces New York City Expansion
-
Wheaton Precious Metals to Release 2024 First Quarter Results on May 9, 2024
-
White Cap Expands Rebar Operations with Acquisition of Crimson Steel Supply, LLC
-
CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS
-
Independence Realty Trust Announces First Quarter 2024 Earnings Release and Conference Call Dates
-
Brunswick Signs Right to Repurchases 0.5% NSR on Select Claims at Mirage
-
SoFi Schedules 2024 Annual Meeting of Stockholders
-
Pinnacle Financial Partners Announces Dates for First Quarter 2024 Earnings Release and Conference Call
-
Sirios grants Brunswick right to purchase a royalty on select claims of the Mirage Property
-
CONTINUOUS AUTONOMOUS CONNECTIVITY FOR WAREHOUSE ROBOTICS ACHIEVED
-
NRSInsights’ March 2024 Retail Same-Store Sales Report
-
Falling Colors To Continue as ASO Following State's Request For Proposals
-
Convocation of the ordinary general shareholders meeting of Invalda INVL
-
Atlas Announces Timing of First Quarter 2024 Earnings Release and Conference Call
-
Oral report | The positive interim analysis results from the Phase III clinical study of Akeso's Cadonilimab (PD-1/CTLA-4 BsAb) plus chemotherapy as first-line treatment for advanced gastric cancer p

